1912 - A tandem CD19/ROR1 CAR-NK to overcome apoptotic resistance in chronic lymphocytic leukemia

Primary Author / Presenter(s)

Andrew Lu, SB

Dana Farber Cancer Institute
Boston, Massachusetts, United States

SE

Salem Elias, MBBS, BSc

Dana Farber Cancer Institute
Boston, Massachusetts, United States
FL

Fuguo Liu, PhD

Dana Farber Cancer Institute
Boston, Massachusetts, United States
HD

Hester Deng, MMSc

Dana Farber Cancer Institute
Boston, Massachusetts, United States
OS

Olivia G. Stringham

Dana Farber Cancer Institute
Boston, Massachusetts, United States
JZ

Jeremy Y. Zhang, BS

Dana Farber Cancer Institute
Boston, Massachusetts, United States
NJ

Nathalie R. Javidi-Sharifi, MD, PhD

Dana Farber Cancer Institute
Boston, Massachusetts, United States
SC

Stephanie A. Chamberlain, BS

Dana Farber Cancer Institute
Boston, Massachusetts, United States
RR

Rizwan Romee, MD

Dana Farber Cancer Institute
Boston, Massachusetts, United States
Matthew S. Davids, MD, MMSc

Director, Clinical Research, Division of Lymphoma; Associate Professor of Medicine
Dana-Farber Cancer Institute
Boston, Massachusetts, United States